ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

640
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
31 Mar 2020 13:10

Celltrion Merger: Potential Controversy from Healthcare's Inventory Situation

Celltrion held the annual general meeting on March 27. During this meeting, CEO Seo reaffirmed the merger between the three siblings. He...

Logo
504 Views
Share
24 Mar 2020 17:51

Short Covering - The New Normal

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 20 March 2020, the...

Logo
504 Views
Share
24 Mar 2020 07:30

Celltrion Seo's Projected Timeline for a COVID-19 Vaccine: Key Takeaways from PR

The three Celltrion siblings had quite a pleasant day yesterday. Celltrion Inc (068270 KS) was up 14.75%, while Celltrion Pharm (068760 KS) almost...

Logo
425 Views
Share
17 Mar 2020 17:37

Short Selling - The Last Hurrah

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 13 March 2020, the...

Logo
432 Views
Share
15 Mar 2020 18:08

The Short Sell Ban Is Here

After tinkering with changes to the short sell rules, the Financial Services Commission (FSC) finally imposed a ban on short selling in the KOSPI,...

Logo
538 Views
Share
x